172 related articles for article (PubMed ID: 19656099)
1. [Alcohol septal ablation and prevention of sudden cardiac death in patients with hypertrophic cardiomyopathy. A case report].
Ardashev AV; Shavarov AA; Dzhandzhgava AO; Rybachenko MS; Kriuchko MIu
Kardiologiia; 2009; 49(6):72-9. PubMed ID: 19656099
[TBL] [Abstract][Full Text] [Related]
2. Management of hypertrophic cardiomyopathy.
Enriquez AD; Goldman ME
Ann Glob Health; 2014; 80(1):35-45. PubMed ID: 24751563
[TBL] [Abstract][Full Text] [Related]
3. Implantable cardioverter-defibrillator therapy for primary prevention of sudden death after alcohol septal ablation of hypertrophic cardiomyopathy.
Cuoco FA; Spencer WH; Fernandes VL; Nielsen CD; Nagueh S; Sturdivant JL; Leman RB; Wharton JM; Gold MR
J Am Coll Cardiol; 2008 Nov; 52(21):1718-23. PubMed ID: 19007692
[TBL] [Abstract][Full Text] [Related]
4. [Hypertrophic cardiomyopathy in 2013].
Giannakopoulos G; Frangos C
Rev Med Suisse; 2013 Mar; 9(376):502, 504-7. PubMed ID: 23534110
[TBL] [Abstract][Full Text] [Related]
5. Ventricular arrhythmia following alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Noseworthy PA; Rosenberg MA; Fifer MA; Palacios IF; Lowry PA; Ruskin JN; Sanborn DM; Picard MH; Vlahakes GJ; Mela T; Das S
Am J Cardiol; 2009 Jul; 104(1):128-32. PubMed ID: 19576333
[TBL] [Abstract][Full Text] [Related]
6. [Sudden cardiac death in familial hypertrophic cardiomyopathy. Identification of high-risk patients].
Pellnitz C; Geier C; Perrot A; Dietz R; Osterziel KJ; Haverkamp W
Dtsch Med Wochenschr; 2005 May; 130(18):1150-4. PubMed ID: 15856398
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of implantable cardioverter-defibrillators for the prevention of sudden death in patients with hypertrophic cardiomyopathy.
Maron BJ; Shen WK; Link MS; Epstein AE; Almquist AK; Daubert JP; Bardy GH; Favale S; Rea RF; Boriani G; Estes NA; Spirito P
N Engl J Med; 2000 Feb; 342(6):365-73. PubMed ID: 10666426
[TBL] [Abstract][Full Text] [Related]
8. Prevention of sudden death in hypertrophic cardiomyopathy: but which defibrillator for which patient?
Boriani G; Maron BJ; Shen WK; Spirito P
Circulation; 2004 Oct; 110(15):e438-42. PubMed ID: 15477422
[No Abstract] [Full Text] [Related]
9. Device therapy in hypertrophic cardiomyopathy.
Beadle R; Williams L
Expert Rev Cardiovasc Ther; 2010 Dec; 8(12):1767-75. PubMed ID: 21108558
[TBL] [Abstract][Full Text] [Related]
10. Transcoronary ablation of septal hypertrophy does not alter ICD intervention rates in high risk patients with hypertrophic obstructive cardiomyopathy.
Lawrenz T; Obergassel L; Lieder F; Leuner C; Strunk-Mueller C; Meyer Zu Vilsendorf D; Beer G; Kuhn H
Pacing Clin Electrophysiol; 2005 Apr; 28(4):295-300. PubMed ID: 15826262
[TBL] [Abstract][Full Text] [Related]
11. Prediction of Sudden Cardiac Arrest After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: ASA-SCARRE Risk Score.
Veselka J; Liebregts M; Cooper R; Faber L; Januska J; Kashtanov M; Tesarkova KH; Hansen PR; Seggewiss H; Shloydo E; Popov K; Hansvenclova E; Polakova E; Ten Berg J; Stables RH; Jarkovsky J; Bonaventura J
Am J Cardiol; 2022 Dec; 184():120-126. PubMed ID: 36192196
[TBL] [Abstract][Full Text] [Related]
12. Implantable cardioverter-defibrillators and prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Maron BJ; Spirito P; Shen WK; Haas TS; Formisano F; Link MS; Epstein AE; Almquist AK; Daubert JP; Lawrenz T; Boriani G; Estes NA; Favale S; Piccininno M; Winters SL; Santini M; Betocchi S; Arribas F; Sherrid MV; Buja G; Semsarian C; Bruzzi P
JAMA; 2007 Jul; 298(4):405-12. PubMed ID: 17652294
[TBL] [Abstract][Full Text] [Related]
13. Predictors of outcome after alcohol septal ablation therapy in patients with hypertrophic obstructive cardiomyopathy.
Chang SM; Lakkis NM; Franklin J; Spencer WH; Nagueh SF
Circulation; 2004 Feb; 109(7):824-7. PubMed ID: 14967729
[TBL] [Abstract][Full Text] [Related]
14. [Management of hypertrophic cardiomyopathy - the most common inherited heart disease].
Magnusson P; Gadler F; Mörner S
Lakartidningen; 2018 Jun; 115():. PubMed ID: 29893985
[TBL] [Abstract][Full Text] [Related]
15. Hypertrophic cardiomyopathy in children.
Wang S; Zhu C
Asian Cardiovasc Thorac Ann; 2022 Jan; 30(1):92-97. PubMed ID: 34569255
[TBL] [Abstract][Full Text] [Related]
16. Risk and Causes of Death in Patients After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy.
Veselka J; Zemánek D; Jahnlová D; Krejčí J; Januška J; Dabrowski M; Bartel T; Tomašov P
Can J Cardiol; 2015 Oct; 31(10):1245-51. PubMed ID: 26095933
[TBL] [Abstract][Full Text] [Related]
17. Cardiology patient page. Hypertrophic cardiomyopathy: a patient perspective.
Nishimura RA; Ommen SR; Tajik AJ
Circulation; 2003 Nov; 108(19):e133-5. PubMed ID: 14609998
[No Abstract] [Full Text] [Related]
18. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention.
Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR
Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262
[TBL] [Abstract][Full Text] [Related]
19. Ambulatory monitoring of aborted sudden cardiac death related to hypertrophic cardiomyopathy.
Vaglio JC; Sorajja P; Gersh BJ
Nat Clin Pract Cardiovasc Med; 2005 Dec; 2(12):659-62; quiz following 662. PubMed ID: 16306922
[TBL] [Abstract][Full Text] [Related]
20. Surgical septal myectomy decreases the risk for appropriate implantable cardioverter defibrillator discharge in obstructive hypertrophic cardiomyopathy.
McLeod CJ; Ommen SR; Ackerman MJ; Weivoda PL; Shen WK; Dearani JA; Schaff HV; Tajik AJ; Gersh BJ
Eur Heart J; 2007 Nov; 28(21):2583-8. PubMed ID: 17483110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
